Medically reviewed by Dr. Shaiek, Plant & Growing Scientist at Luya. Educational content, not medical advice. Do not adjust diabetes treatment based on it.
Your body cannot absorb starch. It has to cut it into sugar first, and the scissors are an enzyme called alpha-amylase. Slow the scissors and the sugar arrives in your blood more gradually — which is precisely how the diabetes drug acarbose works.
So when a 2026 study reported that extracts of sunflower microgreens inhibit alpha-amylase [1], it sounded like a headline. It is a genuinely interesting result. It is also four steps away from your dinner, and this article is about those four steps — because the distance between a positive enzyme assay and a real effect on a human being is where most nutrition claims quietly die.
What the study actually did
Researchers grew sunflower microgreens in soil with and without buffalo manure, made methanol extracts of the harvested greens, and measured how much those extracts suppressed amylase activity in a test tube. The extracts did inhibit the enzyme. The manure, incidentally, made no significant difference to that activity — which was the study's actual question [1].
That is the finding, stated at its true size: an extract of a plant slowed an enzyme in a cuvette.
Step one: an extract is not a food
Methanol extraction concentrates certain compounds and discards everything else — the fibre, the water, the cell walls, the matrix that food actually arrives in. The extract used in an assay may represent the compounds from far more plant material than you would ever eat, delivered without any of the structure that normally controls how fast those compounds are released.
This is not a technicality. It is the single most common reason a promising in-vitro result fails to reproduce in food.
Step two: it was the wrong amylase
The assay used alpha-amylase from Aspergillus oryzae, a fungus [1]. Buying a standardised fungal enzyme is normal practice and makes results comparable between labs, but human salivary and pancreatic amylases are different proteins with different active sites. A compound that binds one does not necessarily bind another.
Step three: a cuvette is not a digestive tract
In a test tube, the inhibitor and the enzyme meet at fixed concentrations, at a fixed pH, undisturbed. In you, the compound has to survive chewing, stomach acid, bile and a wall of gut bacteria; reach the enzyme at a concentration that still matters; and do it while the meal is moving. Plenty of compounds that look potent in glassware never arrive.
Step four: nobody has measured the outcome that matters
The endpoint anyone actually cares about is blood glucose after a meal. Measuring it is not hard — feed people a starch-heavy meal with and without the greens, and track the glucose curve. As far as the published literature goes, this has not been done for any microgreen. A 2024 review of the field says the same thing more diplomatically: clinical trials are still needed before health effects can be established [2].
So is the result worthless?
No — and it is worth being clear about why not, because the honest position is not blanket scepticism.
Enzyme-inhibition assays are how you decide what is worth testing next. This one says sunflower microgreens contain something that interacts with a starch-digesting enzyme, and gives a reason to look at phenolic compounds as the candidate [1]. That is a real contribution. It simply is not a dietary recommendation, and it becomes one only after somebody feeds it to people.
The same logic applies to the broader claim that microgreens help blood sugar. There is one human trial in the vicinity — sulforaphane, from concentrated broccoli sprout extract, in people with type 2 diabetes [3] — and it used a compound at a dose no vegetable portion delivers. We laid the crops out by evidence strength in which microgreens are best for blood sugar.
What to do with this in a kitchen
Nothing dramatic. If you like sunflower microgreens, eat them; they are nutritious for ordinary reasons. If you are managing blood glucose, the interventions with human evidence behind them are the unglamorous ones — what the greens replace on the plate, total carbohydrate, fibre, and the medication your doctor prescribed.
What you should not do is treat a tray of microgreens as an amylase inhibitor. That is a drug's job description, and no food has earned it.
For the other half of the mechanism story — what your gut bacteria do with these plants after digestion is finished — see microgreens and your gut bacteria.
Sources
- Thummajitsakul S, et al. Comparison of chemical constituents, antioxidant, anti-amylase and anti-acetylcholinesterase activities of Helianthus annuus microgreens cultivated from soils with and without buffalo manure. Results in Chemistry 2026;28:103539. https://doi.org/10.1016/j.rechem.2026.103539
- Microgreens: cultivation practices, bioactive potential and health implications. Food Bioscience 2024;62:105133. https://doi.org/10.1016/j.fbio.2024.105133
- Axelsson AS, et al. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. Science Translational Medicine 2017;9(394). https://doi.org/10.1126/scitranslmed.aah4477
